The nature of Asian biopharmaceutical innovation
My paper on global biopharmaceutical productivity has been published in the latest issue of Nature Biotechnology. This paper is a […]
The nature of Asian biopharmaceutical innovation Read Post »
My paper on global biopharmaceutical productivity has been published in the latest issue of Nature Biotechnology. This paper is a […]
The nature of Asian biopharmaceutical innovation Read Post »
MassBio and the Journal of Commercial Biotechnology have partnered to provide MassBio members with free and discounted subscriptions. New MassBio members can get a free
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Legal and regulatory update
Go to paperABSTRACT: The European Commission has launched a public consultation on its proposed amendments to the Medical De…
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post?
What changes will India's next Prime Minister bring to India's Innovative Life Sciences? Read Post »
BIOTECanada and the Journal of Commercial Biotechnology have partnered to provide BIOTECanada members with free and discounted subscriptions. New BIOTECanada
Stem cells are a rapidly developing technology area. The pace of scientific and clinical progress is accompanied by new patents,
Track new stem cell innovations with StemCellPatentWatch Read Post »
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Strategic alliances as a mechanism for wealth creation in the biopharmaceutical industry: An empirical analysis of the Spanish case
Go to paperABSTRACT: …
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Cell therapy: European legal and regulatory implications
Go to paperABSTRACT: This paper reviews some of the legal and regulatory considerations that may a…
Cell therapy: European legal and regulatory implications Read Post »
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Bioterrorism and bioethics: Challenges for industry, government and society
Go to paperABSTRACT: The emerging threat of bioterrorism raises important chall…
Bioterrorism and bioethics: Challenges for industry, government and society Read Post »
This is a guest post by Gerry Langeler, Managing Director with OVP Venture Partners. Do you have a response to Gerry’s
Why do so many scientists fail as entrepreneurs? Read Post »